相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives
Si Ha et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, Synthesis, and Biological Evaluation of Androgen Receptor Degrading and Antagonizing Bifunctional Steroidal Analogs for the Treatment of Advanced Prostate Cancer
Ao Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance
Rana R. McKay et al.
CLINICAL CANCER RESEARCH (2021)
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
Aasems Jacob et al.
CANCERS (2021)
Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer
Xin Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer
Elisa M. Ledet et al.
ONCOLOGIST (2020)
Monomeric Targeted Protein Degraders
Emily J. Hanan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
Ramesh Narayanan
ASIAN JOURNAL OF UROLOGY (2020)
Role of Androgen Receptor in Prostate Cancer: A Review
Kazutoshi Fujita et al.
WORLD JOURNAL OF MENS HEALTH (2019)
Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo
Andrew K. Kwegyir-Afful et al.
CANCERS (2019)
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity
Dong-Jin Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Luo et al.
EUROPEAN UROLOGY (2018)
Improved Procedures for Gram-Scale Synthesis of Galeterone 3β-Imidazole and Galeterone 3β-Pyridine Methoxylate, Potent Androgen Receptor/Mnk Degrading Agents
Puranik Purushottamachar et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2016)
Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure
Haifeng Tang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Alexander W. Wyatt et al.
JAMA ONCOLOGY (2016)
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies
A. Omlin et al.
INVESTIGATIONAL NEW DRUGS (2015)
Discovery and Development of Galeterone (TOK-001 or VN/124-1) for the Treatment of All Stages of Prostate Cancer
Vincent C. O. Njar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo
Andrew K. Kwegyir-Afful et al.
ONCOTARGET (2015)
Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker
Yeon Jae Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
MG132, a proteasome inhibitor, induces apoptosis in tumor cells
Na Guo et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2013)
Drug Safety Is a Barrier to the Discovery and Development of New Androgen Receptor Antagonists
William R. Foster et al.
PROSTATE (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer
Masuo Yamaoka et al.
CLINICAL CANCER RESEARCH (2010)
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
ME Taplin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)